|4Feb 19, 5:12 PM ET

Hanley Jr. Michael Conick 4

4 · Aeglea BioTherapeutics, Inc. · Filed Feb 19, 2020

Insider Transaction Report

Form 4
Period: 2020-02-14
Hanley Jr. Michael Conick
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-02-14+25,00025,000 total
    Exercise: $8.15Exp: 2030-02-13Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 14, 2020, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4